ICON Gross Margin 2012-2025 | ICLR
Current and historical gross margin for ICON (ICLR) over the last 10 years. The current gross profit margin for ICON as of December 31, 2025 is %.
| ICON Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-12-31 | $8.25B | $2.18B | 26.37% |
| 2025-09-30 | $8.10B | $2.27B | 28.07% |
| 2025-06-30 | $8.09B | $2.31B | 28.57% |
| 2025-03-31 | $8.19B | $2.38B | 29.00% |
| 2024-12-31 | $8.28B | $2.44B | 29.42% |
| 2024-09-30 | $8.31B | $2.46B | 29.59% |
| 2024-06-30 | $8.33B | $2.47B | 29.68% |
| 2024-03-31 | $8.23B | $2.44B | 29.61% |
| 2023-12-31 | $8.12B | $2.40B | 29.57% |
| 2023-09-30 | $8.02B | $2.36B | 29.45% |
| 2023-06-30 | $7.90B | $2.32B | 29.38% |
| 2023-03-31 | $7.82B | $2.27B | 29.09% |
| 2022-12-31 | $7.74B | $2.21B | 28.60% |
| 2022-09-30 | $7.66B | $2.16B | 28.20% |
| 2022-06-30 | $7.59B | $2.10B | 27.70% |
| 2022-03-31 | $6.52B | $1.80B | 27.58% |
| 2021-12-31 | $5.48B | $1.51B | 27.52% |
| 2021-09-30 | $4.36B | $1.21B | 27.67% |
| 2021-06-30 | $3.19B | $0.91B | 28.36% |
| 2021-03-31 | $2.94B | $0.84B | 28.54% |
| 2020-12-31 | $2.80B | $0.82B | 29.21% |
| 2020-09-30 | $2.76B | $0.81B | 29.29% |
| 2020-06-30 | $2.77B | $0.81B | 29.31% |
| 2020-03-31 | $2.85B | $0.84B | 29.60% |
| 2019-12-31 | $2.81B | $0.83B | 29.63% |
| 2019-09-30 | $2.76B | $0.81B | 29.50% |
| 2019-06-30 | $2.70B | $0.80B | 29.55% |
| 2019-03-31 | $2.65B | $0.79B | 29.69% |
| 2018-12-31 | $2.60B | $0.78B | 29.97% |
| 2018-09-30 | $2.37B | $0.77B | 32.29% |
| 2018-06-30 | $2.16B | $0.75B | 34.82% |
| 2018-03-31 | $1.95B | $0.74B | 38.03% |
| 2017-12-31 | $1.76B | $0.73B | 41.58% |
| 2017-09-30 | $1.74B | $0.73B | 41.83% |
| 2017-06-30 | $1.72B | $0.72B | 42.08% |
| 2017-03-31 | $1.70B | $0.72B | 42.11% |
| 2016-12-31 | $1.67B | $0.71B | 42.35% |
| 2016-09-30 | $1.64B | $0.70B | 42.57% |
| 2016-06-30 | $1.61B | $0.69B | 42.67% |
| 2016-03-31 | $1.59B | $0.68B | 42.70% |
| 2015-12-31 | $1.58B | $0.67B | 42.29% |
| 2015-09-30 | $1.56B | $0.65B | 41.74% |
| 2015-06-30 | $1.56B | $0.64B | 41.29% |
| 2015-03-31 | $1.54B | $0.63B | 40.66% |
| 2014-12-31 | $1.50B | $0.60B | 39.89% |
| 2014-09-30 | $1.46B | $0.57B | 39.07% |
| 2014-06-30 | $1.41B | $0.54B | 38.13% |
| 2014-03-31 | $1.37B | $0.51B | 37.18% |
| 2013-12-31 | $1.44B | $0.59B | 41.24% |
| 2013-09-30 | $1.39B | $0.57B | 40.99% |
| 2013-06-30 | $1.34B | $0.55B | 40.85% |
| 2013-03-31 | $1.28B | $0.52B | 40.87% |
| 2012-12-31 | $1.21B | $0.49B | 40.46% |
| 2012-09-30 | $1.15B | $0.46B | 40.38% |
| 2012-06-30 | $1.10B | $0.44B | 40.22% |
| 2012-03-31 | $1.06B | $0.43B | 40.47% |
| 2011-12-31 | $1.02B | $0.41B | 39.98% |
| 2011-09-30 | $1.01B | $0.42B | 41.21% |
| 2011-06-30 | $1.00B | $0.42B | 42.27% |
| 2011-03-31 | $0.99B | $0.43B | 43.77% |
| 2010-12-31 | $0.99B | $0.45B | 45.31% |
| 2010-09-30 | $0.99B | $0.45B | 45.94% |
| 2010-06-30 | $0.98B | $0.46B | 46.89% |
| 2010-03-31 | $0.98B | $0.46B | 47.29% |
| 2009-12-31 | $0.89B | $0.38B | 42.84% |
| 2009-09-30 | $0.96B | $0.55B | 57.91% |
| 2009-06-30 | $0.96B | $0.56B | 58.06% |
| 2009-03-31 | $0.96B | $0.46B | 47.97% |
| 2008-12-31 | $0.94B | $0.45B | 48.09% |
| 2008-09-30 | $0.83B | $0.03B | 3.27% |
| 2008-06-30 | $0.77B | $0.00B | 0.52% |
| 2008-03-31 | $0.70B | $0.07B | 10.06% |
| 2007-12-31 | $0.63B | $0.04B | 6.34% |
| 2007-09-30 | $0.58B | $0.25B | 43.52% |
| 2007-06-30 | $0.53B | $0.23B | 42.96% |
| 2007-03-31 | $0.49B | $0.21B | 43.20% |
| 2006-12-31 | $0.46B | $0.20B | 43.74% |
| 2006-09-30 | $0.45B | $0.22B | 48.21% |
| 2006-06-30 | $0.44B | $0.23B | 52.50% |
| 2006-03-31 | $0.42B | $0.27B | 64.44% |
| 2005-12-31 | $0.40B | $0.26B | 65.10% |
| 2005-09-30 | $0.36B | $0.23B | 62.53% |
| 2005-06-30 | $0.37B | $0.23B | 64.11% |
| 2005-03-31 | $0.36B | $0.23B | 63.31% |
| 2004-12-31 | $0.35B | $0.22B | 63.53% |
| 2004-09-30 | $0.35B | $0.22B | 63.77% |
| 2004-06-30 | $0.30B | $0.18B | 59.26% |
| 2004-03-31 | $0.29B | $0.16B | 57.54% |
| 2003-12-31 | $0.29B | $0.18B | 61.32% |
| 2003-09-30 | $0.27B | $0.17B | 62.69% |
| 2003-06-30 | $0.25B | $0.16B | 64.23% |
| 2003-03-31 | $0.22B | $0.14B | 60.54% |
| 2002-12-31 | $0.20B | $0.14B | 72.08% |
| 2002-09-30 | $0.18B | $0.16B | 85.64% |
| 2002-06-30 | $0.17B | $0.17B | 100.00% |
| 2002-03-31 | $0.16B | $0.16B | 100.00% |
| 2001-12-31 | $0.14B | $0.14B | 100.00% |
| 2001-09-30 | $0.13B | $0.13B | 100.00% |
| 2001-06-30 | $0.12B | $0.12B | 100.00% |
| 2001-03-31 | $0.11B | $0.11B | 100.00% |
| 2000-12-31 | $0.10B | $0.10B | 100.00% |
| 2000-09-30 | $0.09B | $0.09B | 100.00% |
| 2000-06-30 | $0.08B | $0.08B | 100.00% |
| 1999-12-31 | $0.06B | $0.06B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.626B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.187B | 24.31 |
| HCA Healthcare (HCA) | United States | $110.772B | 17.53 |
| CVS Health (CVS) | United States | $101.670B | 11.75 |
| Elevance Health (ELV) | United States | $68.432B | 10.33 |
| Cencora (COR) | United States | $62.409B | 19.63 |
| Natera (NTRA) | United States | $27.358B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.501B | 15.87 |
| DiDi Global (DIDIY) | China | $18.026B | 15.96 |
| Viatris (VTRS) | United States | $15.685B | 5.71 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.535B | 0.00 |
| Medpace Holdings (MEDP) | United States | $14.094B | 32.26 |
| BioMerieux (BMXMF) | France | $12.476B | 0.00 |
| Solventum (SOLV) | United States | $11.408B | 10.78 |
| Revvity (RVTY) | United States | $10.039B | 17.71 |
| BrightSpring Health Services (BTSG) | United States | $8.774B | 43.59 |
| Charles River Laboratories (CRL) | United States | $8.667B | 17.09 |
| CochLear (CHEOY) | Australia | $8.030B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.905B | 0.00 |
| HealthEquity (HQY) | United States | $6.586B | 23.20 |
| Bausch + Lomb (BLCO) | Canada | $5.877B | 32.98 |
| GETINGE (GNGBY) | Sweden | $5.626B | 17.96 |
| Avantor (AVTR) | United States | $5.388B | 8.68 |
| PACS (PACS) | United States | $5.304B | 27.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.101B | 0.00 |
| Sotera Health (SHC) | United States | $4.380B | 19.95 |
| Alignment Healthcare (ALHC) | United States | $4.188B | 0.00 |
| Concentras Parent (CON) | United States | $2.818B | 16.12 |
| Organon (OGN) | United States | $2.299B | 2.57 |
| Amplifon S.p.A (AMFPF) | Italy | $2.275B | 13.27 |
| Pediatrix Medical (MD) | United States | $1.782B | 11.11 |
| Establishment Labs Holdings (ESTA) | United States | $1.765B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.746B | 42.28 |
| Surgery Partners (SGRY) | United States | $1.671B | 41.65 |
| Sonida Senior Living (SNDA) | United States | $1.544B | 0.00 |
| Ardent Health (ARDT) | United States | $1.345B | 5.70 |
| Progyny (PGNY) | United States | $1.277B | 25.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.113B | 164.00 |
| Teladoc Health (TDOC) | United States | $0.920B | 0.00 |
| CareDx (CDNA) | United States | $0.822B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.17 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Nutex Health (NUTX) | United States | $0.704B | 11.25 |
| Omada Health (OMDA) | United States | $0.672B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.604B | 99.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Embecta (EMBC) | United States | $0.524B | 2.92 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.435B | 4.70 |
| SBC Medicals (SBC) | United States | $0.426B | 8.47 |
| Forward Industries (FWDI) | United States | $0.375B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.349B | 0.00 |
| Agilon Health (AGL) | United States | $0.316B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| So-Young (SY) | China | $0.262B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Biodesix (BDSX) | United States | $0.133B | 0.00 |
| Beauty Health (SKIN) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.080B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.077B | 0.00 |
| DocGo (DCGO) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |